Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Booking Holdings Inc. insiders sold a net $27.7M of stock across 721 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.
17 earlier Form 4 trades (code P or S) here by this insider (17 sales), the last on Sep 15, 2026.
The trade is 2.1% of the 70,400 shares held after it.
No other insider sold within 30 days.
1,897 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CHIEF HUMAN RESOURCES OFFICER Pisano Paulo sold about $244.6K of BKNG under a 10b5-1 plan on Oct 15, 2026; 1,897 funds added in the latest 13F quarter.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Aug 31, 2026.
The trade is 2.1% of the 71,900 shares held after it.
3 other insiders sold within 30 days.
1,897 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CHIEF HUMAN RESOURCES OFFICER Pisano Paulo sold about $259.5K of BKNG under a 10b5-1 plan on Sep 15, 2026; 3 other insiders sold within 30 days and 1,897 funds added in the latest 13F quarter.
9 earlier Form 4 trades (code P or S) here by this insider (5 buys, 4 sales), the last on Aug 5, 2026.
+4.5% median (+3.5% mean) 90-day return after 3 previous buys.
The trade is 7.1% of the 14,000 shares held after it.
4 other insiders sold within 30 days.
1,897 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director MYLOD ROBERT J JR sold about $200.0K of BKNG under a 10b5-1 plan on Sep 1, 2026; 4 other insiders sold within 30 days and 1,897 funds added in the latest 13F quarter.
15 earlier Form 4 trades (code P or S) here by this insider (15 sales), the last on Nov 7, 2025.
The trade is 4.1% of the 73,400 shares held after it.
4 other insiders sold within 30 days.
1,897 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CHIEF HUMAN RESOURCES OFFICER Pisano Paulo sold about $610.4K of BKNG under a 10b5-1 plan on Aug 31, 2026; 4 other insiders sold within 30 days and 1,897 funds added in the latest 13F quarter.
22 earlier Form 4 trades (code P or S) here by this insider (22 sales), the last on May 26, 2026.
The trade is 2.2% of the 415,750 shares held after it.
4 other insiders sold within 30 days.
1,897 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: EXECUTIVE VP, GENERAL COUNSEL MILLONES PETER J sold about $1.9M of BKNG on Aug 17, 2026; 4 other insiders sold within 30 days and 1,897 funds added in the latest 13F quarter.
721 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
BKNG planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
MYLOD ROBERT J JR
Filed 2026-09-01
$198.4K
WITTMAN VANESSA AMES
Filed 2026-08-17
$79.1K
EWOUT STEENBERGEN
Filed 2026-08-12
$4.3M
MYLOD ROBERT J JR
Filed 2026-08-05
$206.7K
MYLOD ROBERT J JR
Filed 2026-07-29
$1.0M
BKNG mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Select Leisure Portfolio
$42.5M position · as of 2026-05-31
8.9%
FMI Large Cap Fund
$69.5M position · as of 2026-06-30
6.5%
FMI International Fund II - Currency Unhedged
$3.4M position · as of 2026-06-30
6.5%
FMI International Fund
$125.7M position · as of 2026-06-30
6.4%
FMI Global Fund
$690.7K position · as of 2026-06-30
6.0%
Pacer US Cash Cows Growth ETF
$7.5M position · as of 2026-07-31
5.7%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mr. Fogel
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$35.4M
$64.8M
$9.9M
+144%
+38%
2024
$44.8M
$126.4M
$11.7M
+125%
+15%
2023
$46.7M
$139.5M
$15.4M
+59%
-13%
2022
$31.5M
$32.4M
$9.3M
-10%
-41%
2021
$55.1M
$78.2M
$14.3M
+8%
-2%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $27.7M sold by insiders over 180 days, 1,897 funds added last quarter, 1 House member(s) bought in 12 months, disclosed weeks after the trade, $5.7M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$28.2B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM BKNG
FY Dec 2025
$26.9B
FY Dec 2024
$23.7B
FY Dec 2023
$21.4B
FY Dec 2022
$17.1B
FY Dec 2021
$11.0B
Jun 2026
$7.4B
Mar 2026
$5.5B
Dec 2025
$6.3B
Sep 2025
$9.0B
Jun 2025
$6.8B
Mar 2025
$4.8B
Dec 2024
$5.5B
Sep 2024
$8.0B
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM BKNG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$9.5B
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM BKNG
FY Dec 2025
$9.1B
FY Dec 2024
$7.9B
FY Dec 2023
$7.0B
FY Dec 2022
$6.2B
FY Dec 2021
$2.5B
Jun 2026
$3.6B
Mar 2026
$3.1B
Dec 2025
$1.4B
Sep 2025
$1.4B
Jun 2025
$3.1B
Mar 2025
$3.2B
Dec 2024
$645.0M
Sep 2024
$2.3B
At each fiscal year end
Single quarter
Debt to equity
n/a
equity is zero or negative, the ratio has no meaning
Debt to equity BKNG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
4.49x
FY Dec 2021
1.77x
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.49x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt BKNG
FY Dec 2025
0.50x
FY Dec 2024
0.50x
FY Dec 2023
0.52x
FY Dec 2022
0.52x
FY Dec 2021
0.26x
Jun 2026
0.49x
Mar 2026
0.51x
Dec 2025
0.50x
Sep 2025
0.51x
Jun 2025
0.52x
Mar 2025
0.56x
Dec 2024
0.50x
Sep 2024
0.55x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
n/a
fewer than four consecutive quarters of net income
Return on equity BKNG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
n/a
fewer than four consecutive quarters of net income
Return on assets BKNG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
invested capital is zero or negative
Return on invested capital BKNG
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
+223.9%
FY Dec 2022
+75.2%
FY Dec 2021
+35.3%
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+89.9%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed BKNG
FY Dec 2025
+71.7%
FY Dec 2024
+65.5%
FY Dec 2023
+41.8%
FY Dec 2022
+29.8%
FY Dec 2021
+13.9%
Jun 2026
+89.9%
Mar 2026
+96.6%
Dec 2025
+71.7%
Sep 2025
+71.7%
Jun 2025
+73.4%
Mar 2025
+72.2%
Dec 2024
+65.5%
Sep 2024
+53.4%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
1.13x
close 2026-10-27 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing BKNG
FY Dec 2025
1.65x
FY Dec 2024
1.15x
FY Dec 2023
1.19x
FY Dec 2022
1.04x
FY Dec 2021
3.41x
Jun 2026
1.35x
Mar 2026
1.29x
Dec 2025
1.65x
Sep 2025
1.83x
Jun 2025
2.14x
Mar 2025
1.22x
Dec 2024
1.15x
Sep 2024
1.13x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$115.8B
market value at close 2026-10-27 on 2026-07-27 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value BKNG
FY Dec 2025
$8.4B
FY Dec 2024
$7.0B
FY Dec 2023
$7.0B
FY Dec 2022
$3.4B
FY Dec 2021
$3.7B
Jun 2026
$141.1B
Mar 2026
$7.7B
Dec 2025
$8.4B
Sep 2025
$7.5B
Jun 2025
$8.4B
Mar 2025
$6.5B
Dec 2024
$7.0B
Sep 2024
$6.1B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+8.5%
TTM free cash flow over market value at close 2026-10-27
FCF yield BKNG
FY Dec 2025
+131.6%
FY Dec 2024
+120.0%
FY Dec 2023
+141.4%
FY Dec 2022
+197.8%
FY Dec 2021
+63.8%
Jun 2026
+6.9%
Mar 2026
+169.3%
Dec 2025
+131.6%
Sep 2025
+118.8%
Jun 2025
+122.6%
Mar 2025
+140.3%
Dec 2024
+120.0%
Sep 2024
+150.5%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.05x
P/E over trailing EPS growth of 23%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing BKNG
FY Dec 2025
n/a
FY Dec 2024
0.03x
FY Dec 2023
0.02x
FY Dec 2022
0.01x
FY Dec 2021
0.00x
Jun 2026
0.06x
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
0.10x
Dec 2024
0.03x
Sep 2024
0.30x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-27. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
BKNG ranks highest on growth (76th percentile) and financial health (74th), and lowest on insider conviction (5th), among Transport peers.
Financial health
74
Inputs
Debt to equityequity is zero or negative, the ratio has no meaning
Cash flow to debt0.49x · 74 pct, sector of 66
Growth
76
Inputs
Revenue growth, YoY+13.4% · 76 pct, sector of 132
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
5
Inputs
Net Form 4 buying (codes P and S), 180d-$26.3M · 11 pct, sector of 83
Insider buyers, 180d0 · 0 pct, sector of 83
Institutional and government
65
Inputs
Funds adding, latest quarter1,897 · 100 pct, sector of 128
Congress net buyers, 365d-1 · 11 pct, universe of 719
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quarters$3.1M · 83 pct, sector of 30
Risk and compliance
43
Inputs
Short interest, % of float+3.0% · 62 pct, sector of 161
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
New text in Risk Factors, latest 10-K+24.1% · 24 pct, sector of 68
2 not measured: Profitability, US patents
Profitability needs 2 of 4 inputs, 1 present: fewer than four consecutive quarters of net income; invested capital is zero or negative
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
BKNG filings, in plain words
Are Booking insiders buying or selling BKNG?
In the 180 days to 2026-10-28, Booking insiders were net sellers, a net $27.7M across purchases and sales reported on Form 4, by 5 sellers.
Have members of Congress traded BKNG?
Yes. In the year to 2026-10-28, 1 House member disclosed buying BKNG and 2 House members disclosed selling it; the latest on record is a sale by Josh Gottheimer dated 2026-06-01.
Are there planned insider sales of BKNG?
Yes. 5 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $5.7M of stock; the latest, by MYLOD ROBERT J JR, was filed 2026-09-01.
Read the full summary
In the 180 days to 2026-10-28, Booking insiders were net sellers of BKNG, a net $27.7M across purchases and sales reported on Form 4 by 5 sellers. 15% of the 26 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. In the year to 2026-10-28, 1 member of Congress disclosed buying BKNG and 2 members disclosed selling it; the latest on record is a sale by Josh Gottheimer dated 2026-06-01. Insiders filed 5 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $5.7M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.